Th2-like response and antitumor effect of anti-interleukin-4 mAb in mice bearing renal cell carcinoma

Cancer Immunology Immunotherapy

Volumn 43, Issue 6, 1997, Pages 375-381

  Takeuchi, Takumi ^a   Ueki, Tetsuo ^a   Sasaki, Yukihiro ^a   Kajiwara, Takahiro ^a   Li, Baoxing ^a   Moriyama, Nobuo ^a   Kawabe, Kazuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anti IL 4 mAb; Cytokine; Renca; Th1; Th2

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; MONOCLONAL ANTIBODY; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HELPER CELL; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR GROWTH;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA, RENAL CELL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTERLEUKIN-4; KIDNEY NEOPLASMS; MICE; NEOPLASMS, EXPERIMENTAL; TH2 CELLS;

EID: 0031054772     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050347     Document Type: Article

References (26)

1. + T cell immunity. J Exp Med 168:2193
2. Barral Netto M, Barral A, Brownell CE, Skeiky YA, Ellingsworth DR, Twardzik DR, Reed SG (1992) Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science 257:545
3. + tumor-infiltrating lymphocytes. J Exp Med 173:647
4. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF, Gately MK (1993) Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 178:1223
5. Chakraborty NG, Twardzik DR, Sivanandham M, Ergin MT, Hellstrom KE, Mukherji B (1990) Autologous melanoma-induced activation of regulatory T cells that suppress cytotoxic responses. J Immunol 145:2359
6. Del Prete GF, De Carli M, Mastromauro C, Biagiotti R, Macchia D, Falagiani P, Ricci M, Romagnani S (1991) Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 88:346
7. DeWaal Malefyt R, Haanen J, Spits H, Roncarolo MG, Velde Ate Figdor C (1991) Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915
8. Gansbacher B, Zier K, Daniels K, Cronin K, Bannerji R, Gilboa E (1990) Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J Exp Med 172:1217
9. Golumbek PT, Lazenby AJ, Levitsky HI, Jaffee LM, Karasuyama H, Baker M, Pardoll DM (1991) Treatment of established renal cancer by tumor cells engineered to secrete IL-4. Science 254:713
10. + suppressor cell and its mechanisms of action. J Exp Med 171:141
11. Handa K, Suzuki R, Matsui H, Shimizu Y, Kumagi K (1983) Natural killer NK cells as a responder to interleukin 2 (IL-2): IL-2-induced interferon gamma production. J Immunol 130:988
12. Kawakami Y, Custer MC, Rosenberg SA, Lotze MT (1988) IL-4 regulates 1L-2 induction of lymphokine-activated killer activity from lymphocytes. J Immunol 142:3452
13. Larsen CP, Steinman RM, Witmer PM, Hankins DF, Morris PJ, Austyn JM (1990) Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 172:1483
14. Maggi E, Parronchi P, Manetti R, Simonelli C, Piccinni MP, Rugiu FS, De Carli M, Ricci M, Romagnani S (1992) Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 148:2142
15. Morgan CJ, Hernandez CJ, Ward JS, Orosz CG (1993) Detection of cytokin mRNA in vivo by polymerase chain reaction, problems and solutions. Transplantation 56:437
16. Mosmann TR, Moore KW (1992) The role of IL-10 in cross-regulation of Th1 and Th2 responses. Immunol Today 12:A49
17. Mule JJ, Schwarz SL, Roberts AB, Sporn MB, Rosenberg SA (1988) Transforming growth factor-β inhibits the in vitro generation of lymphokine activated killer cells and cytotoxic T cells. Cancer Immunol Immunother 26:95
18. Nakagomi H, Pisa P, Pisa EK, Yamamoto Y, Halapi E, Backlin K, Juhlin C, Kiessling R (1995) Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma. Int J Cancer 63:366
19. Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectant with a novel eukaryotic vector. Gene 108:193
20. Obiri NI, Hillman GG, Haas GP, Sud S, Puri RK (1993) Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4. J Clin Invest 91:88
21. O'Garra A, Chang R, Go N, Hastings R, Haughton G, Howard M (1992) Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 22:711
22. Oswald IP, Gazzinelli RT, Sher A, James SL (1992) IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J Immunol 148:3578
23. Taga K, Mostowski H, Tosato G (1993) Human interleukin 10 can directly inhibit T cell growth. Blood 814:2964
24. Takashima T, Ohnishi K, Tsuyuguchi I, Kishimoto S (1993) Differential regulation of formation of multinucleated giant cells from concanavalin A-stimulated human monocytes by IFN-γ and IL-4. J Immunol 150:3002
25. Takeuchi T, Lowry RP, Konieczny B (1992) Heart grafts in murine systems: the differential activation of Th2-like effectors in peripheral tolerance. Transplantation 53:1281
26. Tepper RI, Coffman RL, Leder P (1992) An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 257:548